CooperVision (CVI) saw revenues increase by a reported 4 percent to $408.5 million in the second quarter of its financial year ended Apr. 30, 2017. In constant currencies, the revenue increase was of 7 percent. Growth was primarily driven by its silicon hydrogel products, with daily silicone hydrogel lenses up ...
Already an Eyewear Intelligence subscriber? Sign in here.
Buying a membership today will give you:
Or sign-up for a trial month for just 9,90€. To continue reading this article register now.